Fund Evaluation Group’s Schwab Emerging Markets Equity ETF SCHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.8M Sell
1,153,361
-71,490
-6% -$2.55M 1.13% 13
2026
Q1
$40.4M Sell
1,224,851
-44,949
-4% -$1.53M 1.24% 11
2025
Q4
$41.6M Buy
1,269,800
+393,094
+45% +$13.1M 1.38% 10
2025
Q3
$29.3M Sell
876,706
-42,179
-5% -$1.33M 1.06% 11
2025
Q2
$27.7M Sell
918,885
-12,525
-1% -$355K 1.07% 12
2025
Q1
$25.7M Buy
931,410
+431,461
+86% +$11.8M 1.11% 10
2024
Q4
$13.3M Buy
499,949
+154,819
+45% +$4.37M 0.62% 13
2024
Q3
$10.1M Sell
345,130
-3,035
-0.9% -$82.1K 0.56% 15
2024
Q2
$9.25M Sell
348,165
-904
-0.3% -$23.6K 0.57% 15
2024
Q1
$8.81M Sell
349,069
-5,862
-2% -$144K 0.55% 17
2023
Q4
$8.8M Buy
354,931
+117,014
+49% +$2.81M 0.64% 17
2023
Q3
$5.7M Sell
237,917
-109,740
-32% -$2.72M 0.51% 19
2023
Q2
$8.56M Buy
+347,657
New +$8.5M 0.79% 13

Other funds holding SCHE

Fund Evaluation Group's SCHE Position: Q2 2026 in Review

Fund Evaluation Group reduced its Schwab Emerging Markets Equity ETF (SCHE) stake by 5.8% in Q2 2026, selling an estimated $2.55M and leaving 1,153,361 shares worth $41.8M. The position accounts for 1.13% of the portfolio, ranked #13.

Fund Evaluation Group first reported a position in SCHE in Q2 2023 and has held it in 13 quarters since. 892 funds tracked by Wall St. Rank hold SCHE as of Q2 2026.

  • Fund Evaluation Group held 1,153,361 shares of Schwab Emerging Markets Equity ETF worth $41.8M as of Q2 2026.
  • Fund Evaluation Group sold 71,490 Schwab Emerging Markets Equity ETF shares in Q2 2026, an estimated $2.55M.
  • Schwab Emerging Markets Equity ETF made up 1.13% of Fund Evaluation Group's portfolio in Q2 2026, its #13 holding.
  • Fund Evaluation Group first reported a position in Schwab Emerging Markets Equity ETF in Q2 2023 and has held it in 13 quarters since.
  • 892 funds tracked by Wall St. Rank held Schwab Emerging Markets Equity ETF as of Q2 2026.

Based on Fund Evaluation Group's 13F filing for Q2 2026, filed 7 Aug 2026.